$EVAX Income Statement | Understand Stock

$EVAX

$3.11 +$0.07 (2.3%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Research and development
General and administrative
Total operating expenses
Operating loss
Finance income
Finance expenses
Net loss before tax
Total income tax benefit for the year
Net loss for the year
Net loss attributable to shareholders of Evaxion A/S
Other comprehensive income that may be reclassified to profit or loss in subsequent periods (net of tax):
Exchange differences on translation of foreign operations
Exchange rate adjustments of investments in subsidiaries
Tax on other comprehensive income/(expense)

Exchange differences on currency translation to presentation currency
Other comprehensive income that will not be reclassified to profit or loss in subsequent periods (net of tax):
Exchange differences on currency translation to presentation currency
Other comprehensive income/(loss) for the year, net of tax
Total comprehensive loss
Total comprehensive loss attributable to shareholders of Evaxion A/S
Loss per share before and after dilution (in dollars per share)

Comments